The Federal Aviation Administration (FAA) has published a unified, performance-based draft regulatory framework for vertical flight infrastructure, removing previous weight and size restrictions to accommodate the incoming generation of Advanced Air Mobility (AAM) aircraft.

Released on October 22, 2026, Draft Advisory Circular 150/5390-4 consolidates and replaces existing heliport and interim vertiport guidance. According to the FAA press release, the 140-page document establishes new safety margins for downwash and outwash and sizes facilities based on specific aircraft dimensions, providing the regulatory clarity required for developers to secure federal infrastructure funding.

Advertisement

Technical shifts in the new draft

The new draft introduces specific geometric and operational standards tailored to powered-lift aircraft, which often possess different flight characteristics than traditional rotorcraft. Among the key technical updates, the draft sets a maximum approach surface slope of 15:1 for powered-lift aircraft. This is significantly shallower than the 8:1 slope standard traditionally applied to Helicopters.

To address the aerodynamic impacts of electric Vertical Takeoff and Landing (eVTOL) designs, the FAA has established a 34.5 mph rotor wash speed threshold. Exceeding this limit triggers a requirement for downwash and outwash caution area markings to protect nearby personnel and property. Additionally, the draft mandates a 10-foot (3-meter) safety margin beyond the aircraft’s rotor diameter to determine the minimum touchdown and liftoff area (TLOF).

“The next generation of aircraft is here, and we are ensuring we have the infrastructure built to support safe takeoffs and landings for them across the National Airspace System,” FAA Administrator Bryan Bedford said in the agency’s announcement.

Replacing interim vertiport guidance

Once finalized, Draft Advisory Circular 150/5390-4 will cancel two existing documents: Advisory Circular 150/5390-2D for heliport design, issued in January 2023, and Engineering Brief 105A for vertiport design, issued in December 2024.

Engineering Brief 105A served as a stopgap measure for early vertiport planning but applied strict limitations. It only covered aircraft with a maximum takeoff weight of 12,500 pounds and a wingspan of 50 feet or less. The new draft lifts these caps entirely. Instead of relying on fixed weight and size categories, the updated framework requires facility designers to size infrastructure around the specific dimensions and performance data of the aircraft intended to use it.

The FAA will host a virtual Industry Day on November 10, 2026, to brief stakeholders on the proposed changes. The public comment period remains open until January 11, 2027, and the agency expects to publish the final design standards in the summer of 2027.

Momentum in the Advanced Air Mobility sector

The infrastructure standards arrive as the AAM sector moves closer to commercialization. The FAA has been gathering real-world operational data through its eVTOL Integration Pilot Program (eIPP), which currently oversees eight projects across 26 states. Recent eIPP milestones include a demonstration flight by BETA Technologies and United Therapeutics transporting a genetically modified pig heart, as well as an automated Cargo aircraft flight conducted by Elroy Air in Louisiana.

Regulatory momentum for the aircraft themselves is also accelerating. On October 21, 2026, U.S. Transportation Secretary Sean P. Duffy announced the issuance of the first Special Airworthiness Market Survey Certificate for an eVTOL aircraft.

Bedford noted the broader economic implications of the sector, stating that the aircraft “have tremendous potential to generate new jobs, connect communities, and strengthen American leadership in aviation.”

AirPro News analysis

The lack of finalized infrastructure standards has been a primary bottleneck for the AAM sector. While aircraft certification programs dominate industry attention, commercial eVTOL operations cannot scale without standardized, FAA-approved vertiports. By shifting to a performance-based model rather than rigid weight categories, the FAA is future-proofing the National Airspace System against rapid design iterations in the powered-lift space.

Crucially, while an Advisory Circular is not a binding regulation in itself, adherence to its standards is mandatory for projects seeking federal airport grants and Passenger Facility Charge (PFC) funding. Finalizing this document in 2027 will unlock federal capital for vertiport construction, shifting AAM infrastructure development from purely private venture funding into the realm of traditional municipal finance.

The Federal Aviation Administration (FAA) launched an interactive online database on October 1, 2026, designed to help pilots and air traffic controllers determine whether specific prescription and over-the-counter medications are acceptable for flight duties.

Dubbed MedGuide, the platform addresses a longstanding information gap that previously required aviators to consult scattered third-party lists or contact Aviation Medical Examiners (AMEs) directly to verify medication compliance. The official release arrives as the agency faces mounting congressional pressure to modernize its aeromedical clearance processes and improve transparency for aviation professionals.

Advertisement

Navigating the new medication database

The initial release of the tool, designated as Version 1.0, intentionally includes only medications that the FAA categorizes as allowed for use during flight or safety-related duties. Users can search for specific pharmacological treatments to verify their compliance status and review any associated operational restrictions.

A core component of the new guidance is the formalization of wait periods. The FAA established a standard minimum wait time required before an aviator can return to the flight deck or radar screen after beginning a new treatment regimen.

“When starting a new medication, in most cases, a 48-hour wait time is required before returning to safety-related duties. This period allows the medication to take effect and ensures no aeromedically significant side effects develop,” the FAA stated in its official MedGuide documentation.

The agency explicitly noted that the presence of a medication on the allowed list does not automatically clear an aviator to fly. The underlying medical condition being treated must also be evaluated for clinical stability. The FAA stressed that the online tool is not intended to replace an individualized assessment by a certified AME.

Industry response to aeromedical transparency

Prior to the launch of MedGuide, pilots and air traffic controllers lacked a centralized, official, and public-facing database to check medication compliance. Aviators frequently had to rely on advisory services provided by industry associations or direct consultations with medical professionals. This fragmented approach often created uncertainty and administrative delays when aviators attempted to verify their medical status before applying for or renewing a medical certificate.

The National Business Aviation Association (NBAA) welcomed the new platform, noting that it provides the definitive guidance flight crews have long requested.

“Pilots are accustomed to clear, if-then directions, and MedGuide offers a more direct way to understand both prescription and over-the-counter medications, including any wait time after an initial or subsequent dose,” said Mark Larsen, Director of Safety and Flight Operations for the NBAA.

Larsen added that the tool equips aviators to make safe, fit-for-flight decisions about medication use, calling the database a significant step in the right direction for the industry.

Legislative mandates and rulemaking origins

The development of MedGuide by the FAA Office of Aerospace Medicine (AAM) stems directly from industry feedback and formal regulatory review. The AAM is responsible for the medical certification of all U.S. civil airmen and the medical clearance of air traffic control specialists, overseeing the national network of AMEs.

On April 1, 2024, the Mental Health and Aviation Medical Clearances Aviation Rulemaking Committee (ARC) issued a report to the FAA containing 24 specific recommendations. The committee identified a critical need for accessible, transparent medical information, which spurred the creation of the MedGuide platform.

The October 1, 2026, launch also coincides with significant legislative action in Washington. On September 24, 2026, the U.S. Senate passed the Aviation Medication Transparency Act of 2026 (S. 3258). The bipartisan bill requires the FAA to publicly list medications that aviation professionals can safely use, as well as those they should avoid, along with specific wait times.

On the same day, the Senate passed the John A. Hauser Mental Health in Aviation Act (S. 3257), which mandates the FAA to update mental health guidance and improve the efficiency of the Special Issuance Medical Certification process. Both bills are currently pending in the U.S. House of Representatives.

Over the next several months, the FAA plans to expand the MedGuide database in subsequent releases. Future iterations will include conditionally acceptable medications, prohibited medications, and guidance on additional underlying medical conditions.

AirPro News analysis

We view the launch of MedGuide as a necessary operational shift for the FAA Office of Aerospace Medicine. By publishing an official, public-facing database, the regulator is moving away from a historically opaque clearance process that often generated anxiety among aviators seeking routine medical care. The timing of Version 1.0 is highly strategic. Releasing the tool just days after the Senate passed S. 3258 allows the FAA to demonstrate proactive compliance with the core requirements of the legislation before it potentially becomes law.

Offloading routine medication queries to an automated, self-service system should incrementally reduce the administrative burden on Aviation Medical Examiners. By empowering pilots to independently verify the status of common over-the-counter and prescription drugs, AMEs and the AAM can theoretically redirect their resources toward processing the persistent backlog of complex Special Issuance cases.

This is original reporting and analysis by AirPro News.

The Federal Aviation Administration (FAA) has proposed a new airworthiness directive (AD) mandating torque inspections on the main rotor servo-controls of 980 Airbus Helicopters AS350, AS355, and EC130 aircraft registered in the United States.

Published as a Notice of Proposed Rulemaking (NPRM) on October 19, 2026, the regulatory action addresses a mechanical vulnerability where paint or protective coating on a nut retainer can cause a loss of tightening torque. If left undetected, the FAA warns this condition could lead to the disconnection of the upper ball bearing end from the main rotor (MR) servo-control. Such a failure would result in a complete loss of helicopter control.

Advertisement

Inspection requirements and compliance timelines

The proposed directive targets specific members of the Airbus Helicopters Ecureuil family. The affected models include the AS350B3, AS355F, AS355F1, AS355F2, AS355N, AS355NP, EC130B4, and EC130T2 helicopters. Under the FAA proposal, operators must perform an initial inspection of the nut tightening torque on the upper ball bearing end of all MR servo-controls within 165 flight hours or six months, whichever occurs first.

The NPRM also outlines strict requirements for follow-up inspections to ensure ongoing safety. Any time an MR servo-control featuring an affected part is installed or reinstalled on an aircraft, maintenance personnel must conduct a subsequent torque check. This secondary inspection must take place between two and 10 flight hours after the installation is complete.

The FAA is accepting public comments on the NPRM through December 3, 2026. Following the closure of the comment period, the agency is expected to review industry feedback and issue a final rule mandating the inspections. The current regulatory action is classified as an interim measure. Airbus Helicopters is actively developing a permanent design change to the nut retainer that will eliminate the problematic paint or protective coating entirely, which will likely prompt further regulatory updates once certified.

Tracing the servo-control vulnerability

The engineering investigation that led to the current NPRM originated with a different Airbus Helicopters product line. In 2024, the European Union Aviation Safety Agency (EASA) received reports of two separate instances where torque was lost between the upper ball bearing end and the MR servo-control on Dauphin and EC155 helicopters. In one of those documented cases, the components completely disconnected in flight.

That discovery prompted EASA to issue an AD for the Dauphin family on June 6, 2024. The FAA subsequently mirrored that action with its own directive for U.S.-registered Dauphin helicopters on July 10, 2025. Following those initial reports, Airbus Helicopters launched a broader engineering analysis to determine the root cause of the torque loss. The manufacturer concluded that the presence of paint or protective coating on the lock washer and nut retainer compromised the friction required to maintain proper tightening torque over time.

During this investigation, the manufacturer determined that the AS350, AS355, and EC130 families share this exact design vulnerability in their main rotor flight control systems. In response to these findings, Airbus Helicopters issued Alert Service Bulletins on April 1, 2026, mandating torque checks across the affected Ecureuil fleet. EASA followed up by issuing AD 2026-0132 on July 8, 2026, to mandate the inspections for European operators. The FAA publication of the NPRM on October 19, 2026, aligns U.S. regulations with the European mandates.

Market context and fleet impact

The Airbus Helicopters Ecureuil family, currently marketed under the H125 and H130 designations, represents one of the most successful light utility helicopter programs in aviation history. Airbus Helicopters has delivered more than 7,200 Ecureuil family aircraft worldwide.

The large number of affected U.S. aircraft reflects the heavy utilization of the type across the country. The AS350 and EC130 platforms are heavily utilized across the aviation industry for critical missions, including law enforcement, emergency medical services, aerial firefighting, powerline maintenance, and passenger transport. The 980 helicopters of U.S. registry represent a significant portion of the active domestic rotorcraft fleet.

AirPro News analysis

The sheer volume of U.S.-registered aircraft affected by this NPRM highlights the industry reliance on the AS350 and EC130 platforms. With 980 airframes requiring initial and recurring torque checks, maintenance providers and fleet operators will need to carefully schedule these inspections to avoid grounding critical public service assets. Because the FAA 165-hour compliance window is relatively short for high-utilization operators like air medical and police units, we expect a rapid mobilization of maintenance personnel once the final rule is published. The recurring inspection requirement for newly installed parts will also add a layer of logistical complexity for maintenance, repair, and overhaul facilities until Airbus Helicopters can field its permanent hardware redesign.